AI in Psychiatric Treatment – Using Machine Learning to Increase Treatment Efficacy in Mental Health
Reporter: Aviva Lev- Ari, PhD, RN
Featuring Start Up: aifred
www.aifredhealth.com
About Us
The inability to predict any given individual’s unique response to psychiatric treatment is a huge bottleneck to recovery from mental health conditions.
To address this challenge, we are creating a deep-learning based clinical decision tool for physicians to bring personalized medicine to psychiatry.
Initially, we will be focusing on treatments for depression, but we plan to scale Aifred to encompass all mental health conditions in order to amplify clinical utility. At its core, aifred is leveraging the collective intelligence of the scientific and medical community to bring better healthcare to all.
We are a proud official IBM Watson AI XPrize team, headquartered in Montreal, Canada.Read more about us:
Deep Learning
Something unique to every machine learning company is the precise nature of their hyperparameter optimization and goals of their model. We will optimize aifred with the help of a distributed network of domain experts in psychiatry — a collaboration unique to aifred health. We are implementing attention networks responsible for removing the “black-box” nature of neural networks. As well, we are analyzing the quality of model predictions, allowing both for greater interpretability of model decisions and the generation of new basic research questions, which are going to be unique to the data-set and optimization techniques we develop in-house. By training aifred on reliable datasets, we are able to ensure quality input to our model. De-identified patient outcomes will feed back into our neural networks to continuously improve aifred’s predictive power. Feature engineering is an important part of determining which inputs go into a network and varies how it’s done for every team- once again, this will be undertaken with the support of diverse group of experts we are recruiting.
Our Product
![]()
Treatment Prediction
The aifred solution makes use of innovative and powerful machine learning techniques predict treatment efficacy based on an array of patient characteristics.
![]()
Interpretability
Forget the blackbox! Our system will provide a report highlighting the most significant features that led to a treatment prediction.
![]()
Patient Data Tracking
Track patient symptoms and test results to monitor outcomes or make new predictions. Banks of standardized questionnaires, data visualization, scheduling software — all of it modular and capable of being tailored to clinicians’ needs.
![]()
Electronic Patient Record
Keep all important patient information in one place, and get insights using our analytics.
In the News:
Montreal Gazette article written about our startup:
Press about us winning first place globally in the IBM Watson AI XPrize milestone competition
Forbes article that features our CTO, Robert Fratila:
https://www.forbes.com/sites/insights-intelai/2018/11/29/5-entrepreneurs-on-the-rise-in-ai/
Post about our graduation from the prestigious creative destruction lab program:
McGill University article featuring us:
REFERENCE
The Incredible Ways Artificial Intelligence Is Now Used In Mental Health
Bernard Marr 12:23 am
4 Benefits of using AI to help solve the mental health crisis
There are several reasons why AI could be a powerful tool to help us solve the mental health crisis. Here are four benefits:
- Support mental health professionals
As it does for many industries, AI can help support mental health professionals in doing their jobs. Algorithms can analyze data much faster than humans, can suggest possible treatments, monitor a patient’s progress and alert the human professional to any concerns. In many cases, AI and a human clinician would work together.
- 24/7 access
Due to the lack of human mental health professionals, it can take months to get an appointment. If patients live in an area without enough mental health professionals, their wait will be even longer. AI provides a tool that an individual can access all the time, 24/7 without waiting for an appointment.
- Not expensive
The cost of care prohibits some individuals from seeking help. Artificial intelligent tools could offer a more accessible solution.
- Comfort talking to a bot
While it might take some people time to feel comfortable talking to a bot, the anonymity of an AI algorithm can be positive. What might be difficult to share with a therapist in person is easier for some to disclose to a bot.
Other related articles published in this Open Access Online Scientific Journal include the following:
Resources on Artificial Intelligence in Health Care and in Medicine:
Articles of Note at PharmaceuticalIntelligence.com @AVIVA1950 @pharma_BI
Curator: Aviva Lev-Ari, PhD, RN
https://www.linkedin.com/pulse/resources-artificial-intelligence-health-care-note-lev-ari-phd-rn/
R&D for Artificial Intelligence Tools & Applications: Google’s Research Efforts in 2018
Reporter: Aviva Lev-Ari, PhD, RN
McKinsey Top Ten Articles on Artificial Intelligence: 2018’s most popular articles – An executive’s guide to AI
Reporter: Aviva Lev-Ari, PhD, RN
LIVE Day Three – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 10, 2019
LIVE Day Two – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 9, 2019
LIVE Day One – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8, 2019
The Regulatory challenge in adopting AI
Author and Curator: Dror Nir, PhD
https://pharmaceuticalintelligence.com/2019/04/07/the-regulatory-challenge-in-adopting-ai/
VIDEOS: Artificial Intelligence Applications for Cardiology
Reporter: Aviva Lev-Ari, PhD, RN
Artificial Intelligence in Health Care and in Medicine: Diagnosis & Therapeutics
Reporter: Aviva Lev-Ari, PhD, RN
World Medical Innovation Forum, Partners Innovations, ARTIFICIAL INTELLIGENCE | APRIL 8–10, 2019 | Westin, BOSTON
https://worldmedicalinnovation.org/agenda/
Digital Therapeutics: A Threat or Opportunity to Pharmaceuticals
Reporter and Curator: Dr. Sudipta Saha, Ph.D.
The 3rd STATONC Annual Symposium, April 25-27, 2019, Hilton Hartford, CT, 315 Trumbull St., Hartford, CT 06103
Reporter: Stephen J. Williams, Ph.D.
2019 Biotechnology Sector and Artificial Intelligence in Healthcare
Reporter: Aviva Lev-Ari, PhD, RN
The Journey of Antibiotic Discovery
Reporter and Curator: Dr. Sudipta Saha, Ph.D.
https://pharmaceuticalintelligence.com/2019/05/19/the-journey-of-antibiotic-discovery/
Artificial intelligence can be a useful tool to predict Alzheimer
Reporter: Irina Robu, PhD
HealthCare focused AI Startups from the 100 Companies Leading the Way in A.I. Globally
Reporter: Aviva Lev-Ari, PhD, RN
2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts | Westin Copley Place
https://worldmedicalinnovation.org/
MedCity Converge 2018 Philadelphia: Live Coverage @pharma_BI
Reporter: Stephen J. Williams
IBM’s Watson Health division – How will the Future look like?
Reporter: Aviva Lev-Ari, PhD, RN
Live Coverage: MedCity Converge 2018 Philadelphia: AI in Cancer and Keynote Address
Reporter: Stephen J. Williams, PhD
HUBweek 2018, October 8-14, 2018, Greater Boston – “We The Future” – coming together, of breaking down barriers, of convening across disciplinary lines to shape our future
Reporter: Aviva Lev-Ari, PhD, RN
Role of Informatics in Precision Medicine: Notes from Boston Healthcare Webinar: Can It Drive the Next Cost Efficiencies in Oncology Care?
Reporter: Stephen J. Williams, Ph.D.
Gene Editing with CRISPR gets Crisper
Curators: Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
https://pharmaceuticalintelligence.com/2016/05/03/gene-editing-with-crispr-gets-crisper/
Disease related changes in proteomics, protein folding, protein-protein interaction
Curator: Larry H. Bernstein, MD, FCAP
Can Blockchain Technology and Artificial Intelligence Cure What Ails Biomedical Research and Healthcare
Curator: Stephen J. Williams, Ph.D.
N3xt generation carbon nanotubes
Curator: Larry H. Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2015/12/14/n3xt-generation-carbon-nanotubes/
Healthcare conglomeration to access Big Data and lower costs
Curator: Larry H. Bernstein, MD, FCAP
Mindful Discoveries
Curator: Larry H. Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2016/01/28/mindful-discoveries/
Synopsis Days 1,2,3: 2018 Annual World Medical Innovation Forum Artificial Intelligence April 23–25, 2018 Boston, Massachusetts | Westin Copley Place
Curator: Aviva Lev-Ari, PhD, RN
Unlocking the Microbiome
Curator: Larry H. Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2016/02/07/unlocking-the-microbiome/
Linguamatics announces the official launch of its AI self-service text-mining solution for researchers.
Reporter: Aviva Lev-Ari, PhD, RN
Novel Discoveries in Molecular Biology and Biomedical Science
Curator: Larry H. Bernstein, MD, FCAP
Biomarker Development
Curator: Larry H. Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2015/11/16/biomarker-development/
Imaging of Cancer Cells
Curator: Larry H. Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2016/04/20/imaging-of-cancer-cells/
Future of Big Data for Societal Transformation
Curator: Larry H. Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2015/12/14/future-of-big-data-for-societal-transformation/
mRNA Data Survival Analysis
Curators: Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
https://pharmaceuticalintelligence.com/2016/06/18/mrna-data-survival-analysis/
Applying AI to Improve Interpretation of Medical Imaging
Author and Curator: Dror Nir, PhD
Leave a Reply